Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

Electronic cigarette, effective or harmful for quitting smoking and respiratory health: A quantitative review papers.

Related Articles

Electronic cigarette, effective or harmful for quitting smoking and respiratory health: A quantitative review papers.

Lung India. 2017 Jan-Feb;34(1):25-28

Authors: Heydari G, Ahmady AE, Chamyani F, Masjedi M, Fadaizadeh L

Abstract
BACKGROUND: In recent years, electronic cigarettes (ECs) have been heavily advertised as an alternative smoking device as well as a possible cessation method. We aimed to review all published scientific literature pertaining to ECs and to present a simple conclusion about their effects for quitting smoking and respiratory health.
METHODS: This was a cross-sectional study with a search of PubMed, limited to English publications upto September 2014. The total number of papers which had ECs in its title and their conclusions positive or negative regarding ECs effects were computed. The number of negative papers was subtracted from the number of positive ones to make a score.
RESULTS: Of the 149 articles, 137 (91.9%) were accessible, of which 68 did not have inclusion criteria. In the 69 remaining articles, 24 studies supported ECs and 45 considered these to be harmful. Finally, based on this evidence, the score of ECs (computed result with positive minus negative) was -21.
CONCLUSION: Evidence to suggest that ECs may be effective and advisable for quitting smoking or a safe alternative for smoking is lacking and may instead harm the respiratory system. However, further studies are needed.

PMID: 28144056 [PubMed - in process]

Epidemiological profile of acute respiratory distress syndrome patients: A tertiary care experience.

Related Articles

Epidemiological profile of acute respiratory distress syndrome patients: A tertiary care experience.

Lung India. 2017 Jan-Feb;34(1):38-42

Authors: Magazine R, Rao S, Chogtu B, Venkateswaran R, Shahul HA, Goneppanavar U

Abstract
BACKGROUND: Acute respiratory distress syndrome (ARDS) is seen in critically ill patients. Its etiological spectrum in India is expected to be different from that seen in western countries due to the high prevalence of tropical infections.
AIM: To study the epidemiological profile of ARDS patients.
SETTING: A tertiary care hospital in Karnataka, India.
MATERIALS AND METHODS: Retrospective analysis of 150 out of the 169 ARDS patients diagnosed during 2010-2012. Data collected included the clinical features and severity scoring parameters.
RESULTS: The mean age of the study population was 42.92 ± 13.91 years. The causes of ARDS included pneumonia (n = 35, 23.3%), scrub typhus (n = 33, 22%), leptospirosis (n = 11, 7.3%), malaria (n = 6, 4%), influenza (H1N1) (n = 10, 6.7%), pulmonary tuberculosis (n = 2, 1.3%), dengue (n = 1, 0.7%), abdominal sepsis (n = 16, 10.7%), skin infection (n = 3, 2%), unknown cause of sepsis (n = 18, 12%), and nonseptic causes (n = 15, 10%). A total of 77 (51.3%) patients survived, 66 (44%) expired, and 7 (4.7%) were discharged against medical advice (AMA). Preexisting comorbidities (46) were present in 13 survivors, 19 nonsurvivors, and four discharged AMA. History of surgery prior to the onset of ARDS was present in one survivor, 13 nonsurvivors, and one discharge AMA. Mean Acute Physiology and Chronic Health Evaluation (APACHE) II, APACHE III, and Sequential Organ Failure Assessment scores in survivors were 9.06 ± 4.3, 49.22 ± 14, and 6.43 ± 2.5 and in nonsurvivors 21.11 ± 7, 86.45 ± 23.5, and 10.6 ± 10, respectively.
CONCLUSION: The most common cause of ARDS in our study was pneumonia, but a large percentage of cases were due to the tropical infections. Preexisting comorbidity, surgery prior to the onset of ARDS, higher severity scores, and organ failure scores were more frequently observed among nonsurvivors than survivors.

PMID: 28144059 [PubMed - in process]

Pulmonary tuberculosis - An emerging risk factor for venous thromboembolism: A case series and review of literature.

Related Articles

Pulmonary tuberculosis - An emerging risk factor for venous thromboembolism: A case series and review of literature.

Lung India. 2017 Jan-Feb;34(1):65-69

Authors: Gupta A, Mrigpuri P, Faye A, Bandyopadhyay D, Singla R

Abstract
One-third of patients with symptomatic venous thromboembolism (VTE) manifest pulmonary embolism, whereas two-thirds manifest deep vein thrombosis (DVT). Overall, 25%-50% of patients with first-time VTE have an idiopathic condition, without a readily identifiable risk factor, and its association with tuberculosis (TB) is a rare occurrence. Deep venous thrombosis has been associated with 1.5%-3.4% cases of TB. Early initiation of anti-TB treatment along with anticoagulant therapy decreases the overall morbidity and mortality associated with the disease. We report three cases of DVT associated with pulmonary TB who were diagnosed due to high index of suspicion as the risk factors for the development of DVT were present in these cases.

PMID: 28144063 [PubMed - in process]

Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Related Articles

Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

J Clin Invest. 2017 Feb 01;127(2):405-414

Authors: Mora AL, Bueno M, Rojas M

Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic age-related lung disease with high mortality that is characterized by abnormal scarring of the lung parenchyma. There has been a recent attempt to define the age-associated changes predisposing individuals to develop IPF. Age-related perturbations that are increasingly found in epithelial cells and fibroblasts from IPF lungs compared with age-matched cells from normal lungs include defective autophagy, telomere attrition, altered proteostasis, and cell senescence. These divergent processes seem to converge in mitochondrial dysfunction and metabolic distress, which potentiate maladaptation to stress and susceptibility to age-related diseases such as IPF. Therapeutic approaches that target aging processes may be beneficial for halting the progression of disease and improving quality of life in IPF patients.

PMID: 28145905 [PubMed - in process]

Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.

Related Articles

Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.

Int J Mol Sci. 2017 Jan 29;18(2):

Authors: Franco MD, Lucchino B, Spaziante M, Iannuccelli C, Valesini G, Iaiani G

Abstract
Systemic rheumatic diseases have significant morbidity and mortality, due in large part to concurrent infections. The lung has been reported among the most frequent sites of infection in patients with rheumatic disease, who are susceptible to developing pneumonia sustained both by common pathogens and by opportunistic microorganisms. Patients with rheumatic disease show a peculiar vulnerability to infectious complications. This is due in part to intrinsic disease-related immune dysregulation and in part to the immunosuppressive treatments. Several therapeutic agents have been associated to a wide spectrum of infections, complicating the management of rheumatic diseases. This review discusses the most frequent pulmonary infections encountered in rheumatic diseases, focusing on opportunistic agents, consequent diagnostic challenges and appropriate therapeutic strategies.

PMID: 28146077 [PubMed - in process]

Search